CHINA RESOURCES PHARMACEUTICAL INDUSTRY INVESTMENT FUND
CHINA RESOURCES PHARMACEUTICAL INDUSTRY INVESTMENT FUND
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-01-06 | 3D Medicines | China Resources Pharmaceutical Industry Investment Fund investment in Venture Round - 3D Medicines | 280 M CNY |
More informations about "China Resources Pharmaceutical Industry Investment Fund"
CR Capital Management - crcapm.com
CEO, CR Pharmaceutical Fund. Mr. Tang used to be the General Manager of Yunnan Yingmao Honghe Pharmaceutical Co., Ltd., the Investment Director of the Investment Headquarters of Shanghai Fosun Pharmaceutical (Group) Co., …See details»
CR Capital Management - crcapm.com
Managing Director, CCT Industry Pilot Fund. Mr. Wang used to be the Associate Director of the Investment Department at CR Capital Management, the Senior Manager of China Resources Financial Holdings, the Investment Manager of …See details»
China Resources Pharmaceutical Industry Investment Fund
Jan 6, 2020 Number of Lead Investments 1 China Resources Pharmaceutical Industry Investment Fund has invested in 3D Medicines on Jan 6, 2020 . This investment - Venture …See details»
China Resources Pharmaceutical Industry Investment Fund
China Resources Pharmaceutical Industry Investment Fund. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Investment …See details»
3D Medicines - Funding, Financials, Valuation & Investors
Organization. 3D Medicines . Connect to CRM . Save . Summary. Financials. People. Technology. ... China Resources Pharmaceutical Industry Investment Fund: Nov 22, 2017: ...See details»
Week in Review: China Resources Pharma Files for $369 Million …
Oct 28, 2017 Deals and Financings China Resources Pharma announced plans to raise $368.5 million for a China life science investment fund; Chi-Med (Hutchison China MediTech) …See details»
CR Pharm Files for $368.5 Million China Pharma Fund
Oct 25, 2017 China Resources Pharmaceutical filed with the Hong Kong exchange to raise $368.5 million in an investment fund. The fund will be run by its subsidiary, CR Pharm …See details»
China Resources Pharmaceutical Group Ltd Registered Shs Unitary …
Jul 25, 2022 Morningstar is an investment research company offering mutual fund, ETF, and stock analysis, ratings, and data, and portfolio tools. Discover actionable insights today. ...See details»
Week In Review: China Resources Pharma Files For $369 Million …
Oct 29, 2017 China Resources Pharmaceutical (HK: 3320) filed with the Hong Kong exchange to raise $368.5 million in an investment fund. The fund will be run by its subsidiary, CR Pharm …See details»
China Resources unit mulls US$377m fund to ride on health care …
Oct 25, 2017 China Resources Pharmaceutical has proposed to commit 305.25 million yuan or 12.21 per cent of the capital for the fund. ... Shenzhen Harvest Huaji Equity Investment will be …See details»
China Resources Pharmaceutical Group Limited: Shareholders …
May 31, 2016 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally …See details»
China Resources Pharmaceutical Group Is the Third-Largest …
Aug 30, 2024 The medical distribution industry in China is in a fast-paced consolidation process. CR Pharma has a 10-year historical average return on investment of 18.4%, higher than its …See details»
Company China Resources Pharmaceutical Group Limited
May 31, 2016 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally …See details»
CR Pharma joins China's IPO wave with $2B offering to fund …
Oct 12, 2016 Known as CR Pharma, the drugmaker--part of the state-owned China Resources Holdings conglomerate--is hoping to sell 1.54 billion shares at between HK$8.45 and …See details»
China Resources Pharma Restructures for Industry Growth
Nov 21, 2024 China Resources Pharmaceutical Group Ltd. is undergoing an internal reorganization aimed at enhancing its influence in the panax notoginseng industry by selling a …See details»
MiRXES Board of Directors welcomes strategic investor Da Liu …
Sep 21, 2021 The fund is mandated to invest in leading life science companies that develop innovative drugs and therapies, medical technology and smart healthcare technology. About …See details»
China Resources Pharmaceutical Group - Crunchbase
Investment Firm. China Resources Pharmaceutical Group . Connect to CRM . Save . Summary. Financials. ... China Resources Pharmaceutical Group has raised a total of . obfuscated. …See details»
China Resources Pharmaceutical Holdings Company Limited
Find company research, competitor information, contact details & financial data for China Resources Pharmaceutical Holdings Company Limited of Beijing, Beijing. Get the latest …See details»
China Resources Pharma Signs Major IT Services Deal
4 days ago China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wall …See details»
CMO in Pharmaceutical Industry Market Research 2024-2028: …
1 day ago The CMO in pharmaceutical industry market size is forecast to increase by USD 40.6 million at a CAGR of 6.6% between 2023 and 2028. The pharmaceutical industry's CMO …See details»